| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
08-24-2014, 04:14 PM
|
#12 | |||
|
||||
|
Senior Member
|
I did find this, from 2008. Two of the authors are among the inventors of Copaxone, and the study was sponsored in part by Teva, the company that makes Copaxone, but the study results might still be worth considering. They are talking about experimental autoimmune encephalitis in mice, though it is the closest thing to an animal model for MS that there is.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2516229/
__________________
Repeal the law of gravity! MS diagnosed 1980. Type 2 diabetes, osteoarthritis, osteopenia. Avonex 2002-2005. Copaxone 6/4/07-5/15/10. Currently: Glatopa (generic Copaxone), 40mg 3 times/week, 12/16/20 - 3/16/24 |
|||
|
 Reply With Quote
|
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Clinical Trial of Remyelination Drug | Multiple Sclerosis | |||
| New probable drug treatment could aid in remyelination in multiple sclerosis (Topix) | Multiple Sclerosis | |||
| Remyelination possible? | Multiple Sclerosis | |||
| New research on remyelination | Multiple Sclerosis | |||
| Remyelination- A new Role For NT | Multiple Sclerosis | |||
Threaded Mode